| Literature DB >> 35040917 |
Weijing Cheng1, Yunhe Song1, Fengbin Lin1, Jian Xiong1, Fei Li1, Ling Jin1, Zhenyu Wang1, Chunman Yang2, Bin Yang3, Fanyin Wang4, Guili Ning5, Wei Wang1, Xiulan Zhang1.
Abstract
Purpose: To evaluate the frequency of and identify the factors that influence the artifacts of swept-source optical coherence tomography angiography (SS-OCTA) in glaucomatous and normal eyes.Entities:
Mesh:
Year: 2022 PMID: 35040917 PMCID: PMC8764211 DOI: 10.1167/tvst.11.1.23
Source DB: PubMed Journal: Transl Vis Sci Technol ISSN: 2164-2591 Impact factor: 3.283
Figure 1.Examples of different types of scanning artifacts, both binarized and pseudo-color images in SS-OCTA imaging. (A) Normal image. Overall image quality and resolution were high without any artifacts. (B) Decentration. The foveal avascular zone region is off-center of the image, with partial vessels located outside the image. (C) Motion. Disruption of vascular signal with partial loss of microvascular signal (binary image, yellow arrows). (D) Defocus. Blurred macrovascular signal with severe loss of microvascular signal. (E) Segmentation errors. In the B-scan images, an error occurred in the internal limiting membrane/inner nuclear layer auto-stratification algorithm, and the corresponding en face vascular images are not at the same layer. Hot colors on the pseudo-color images are higher density. (F) Masking type 1. A vitreous floater obscures vessels, which results in irregular areas of partial microvascular signal loss (binary images, yellow arrows). (G) Masking type 2. Another type of irregular areas of partial microvascular signal loss. (H) Masking type 3. The patient blinks frequently, resulting in a loss of local horizontal linear signal loss that appears as horizontal black lines (binary images, yellow arrows). (I) Masking type 4. Inferior regular microvascular signal loss. (J) Masking type 5. Superior regular microvascular signal loss.
Demographic and Clinical Characteristics of Included Participants
| Characteristic | Overall | Normal | Glaucoma |
|
|---|---|---|---|---|
| No. of subjects (eyes) | 4426 (4426) | 3063 (3063) | 1363 (1363) | — |
| Age (y), mean ± SD | 54.31 ± 15.69 | 59.56 ± 12.76 | 42.42 ± 15.22 |
|
| Female gender, | 2381 (53.78) | 1979 (64.62) | 402 (29.49) |
|
| BCVA (logMAR), mean ± SD | 0.16 ± 0.16 | 0.08 ± 0.15 | 0.09 ± 0.16 | 0.563 |
| IOP (mmHg), | 15.76 ± 3.10 | 15.26 ± 3.66 | 15.90 ± 2.90 |
|
| AL (mm), mean ± SD | 24.23 ± 1.64 | 23.77 ± 1.38 | 25.46 ± 1.65 |
|
| IQS, mean ± SD | 55.59 ± 10.42 | 57.32 ± 11.26 | 51.65 ± 6.63 |
|
IOP, intraocular pressure.
P values are for comparisons between the normal group and the glaucoma group. Bold indicates statistical significance.
All glaucoma eyes had been receiving multiple IOP-lowering eye drops.
Figure 2.Frequency of the five types of artifacts in a total of 4426 scans from 4426 subjects using SS-OCTA.
Prevalence of Artifacts Among the Normal and Glaucoma Eyes
| Artifacts | Overall | Normal | Glaucoma |
|
|---|---|---|---|---|
| Any artifacts | 1086 (24.54) | 659 (21.51) | 427 (31.33) |
|
| Motion | 705 (15.93) | 469 (15.31) | 236 (17.31) | 0.461 |
| Defocus | 628 (14.19) | 337 (11.00) | 291 (21.35) |
|
| Decentration | 134 (3.03) | 78 (2.55) | 56 (4.11) |
|
| Masking | 62 (1.40) | 40 (1.31) | 22 (1.61) | 0.569 |
| Segmentation errors | 23 (0.52) | 18 (0.59) | 5 (0.37) | 0.346 |
| Others | 18 (0.41) | 6 (0.20) | 12 (0.88) | 0.478 |
P values are for comparisons between the normal group and the glaucoma group. Bold indicates statistical significance.
Univariate and Multivariate Logistic Regression Analysis for Identifying Factors Associated With the Presence of Any Artifacts in All Subjects
| Univariate | Multivariate | |||
|---|---|---|---|---|
| Factors | OR (95% CI) |
| OR (95% CI) |
|
| Age, per year | 0.99 (0.99–0.99) |
| 1.00 (0.99–1.01) | 0.504 |
| Gender, female | 0.97 (0.86–1.10) | 0.660 | — | — |
| IOP, per mmHg | 0.97 (0.95–0.99) |
| 0.99 (0.97–1.02) | 0.591 |
| IQS | ||||
| More than 40 | Ref. (1.0) | — | Ref. (1.0) | — |
| Less than 40 | 3.87 (3.36–4.45) |
| 3.75 (3.15–4.48) |
|
| BCVA, per logMAR | 0.84 (0.42–1.31) | 0.648 | — | — |
| AL, per mm | 1.24 (1.19–1.29) |
| 1.06 (1.00–1.13) | 0.050 |
| Presence of glaucoma | 1.88 (1.65–2.14) |
| 2.71 (2.09–3.51) |
|
Bold indicates statistical significance.
Univariate and Multivariate Logistic Regression Analysis for the Presence of Any Artifacts in Subgroups of Glaucoma and Normal Subjects
| Univariate | Multivariate | |||
|---|---|---|---|---|
| Factors | OR (95% CI) |
| OR (95% CI) |
|
|
| ||||
| Age, per year | 0.99 (0.99–1.00) |
| 0.98 (0.96–0.99) | 0.059 |
| Gender, female | 1.31 (1.12–1.52) |
| 1.34 (1.12–1.61) |
|
| IOP, per mmHg | 0.98 (0.95–1.00) | 0.073 | 0.99 (0.96–1.02) | 0.493 |
| IQS | ||||
| More than 40 | Ref. (1.0) | — | Ref. (1.0) | — |
| Less than 40 | 4.02 (3.39–4.78) |
| 3.74 (3.09–4.54) |
|
| BCVA, per logMAR | 0.77 (0.47–1.27) | 0.308 | — | — |
| AL, per mm | 1.19 (1.13–1.26) |
| 1.09 (1.02–1.17) |
|
|
| ||||
| Age, per year | 1.01 (1.01–1.02) |
| 0.99 (0.97–1.00) | 0.163 |
| Gender, female | 1.01 (0.80, 1.28) | 0.918 | — | — |
| IOP, per mmHg | 1.01 (0.97, 1.06) | 0.553 | — | — |
| IQS | ||||
| More than 40 | Ref. (1.0) | — | Ref. (1.0) | — |
| Less than 40 | 3.21 (2.51–4.12) |
| 2.84 (1.82–4.43) |
|
| BCVA, per logMAR | 0.97 (0.67–1.37) | 0.308 | — | — |
| AL, per mm | 1.07 (0.99–1.15) | 0.0715 | 0.92 (0.80–1.06) | 0.238 |
| Stage of glaucoma | ||||
| Mild | Ref. (1.0) | — | Ref. (1.0) | — |
| Moderate | 1.73 (1.23–2.43) |
| 1.59 (0.94–2.69) | 0.084 |
| Advanced | 4.20 (2.73–6.47) |
| 2.17 (1.02–4.64) |
|
Bold indicates statistical significance.
Figure 3.The ROC curves of IQSs for diagnosing any artifacts and each specific artifact. The diagnostic performance for (A) any artifact (AUC = 0.723); (B) masking (AUC = 0.507); (C) decentration (AUC = 0.527); (D) motion (AUC = 0.616); (E) defocus (AUC = 0.714); and (F) segmentation errors (AUC = 0.851). ILM, inner limiting membrane; IPL, inner plexiform layer; INL, inner nuclear layer.
Figure 4.Example of the report of image quality for five typical artifacts. (A) High IQS without artifact. (B) High IQS with masking. (C) High IQS with decentration. (D) High IQS with motion. (E) High IQS with defocus. (F) High IQS with segmentation error.
Previous Reports on the Frequency and Potential Factors Influencing the Presence of Artifacts in OCTA Imaging
| Study | Subjects | Device | Eyes | Motion | Defocus | Decentration | Masking | Segmentation Errors | Influential Factors |
|---|---|---|---|---|---|---|---|---|---|
| Holmen et al. | Retinal diseases | SD-OCTA | 406 | 16.00% | 20.90% | 21.40% | 26.90% | 24.60% | NS |
| Cui et al. | Retinal diseases | SS-OCTA | 136 | — | — | — | — | 13.24% | NS |
| Enders et al. | Retinal diseases | SD-OCTA | 75 | 49.30% | — | 9.30% | — | 54.67% | NS |
| Iftikhar et al. | MS and healthy | SD-OCTA | 385 | 96.30% | — | 25.10% | 51.90% | — | Age, sex, visual acuity, MS, optic neuritis |
| Ghasemi et al. | Retinal diseases | SS-OCTA | 57 | 49.10% | — | 1.70% | 1.70% | 61.40% | Presence of choroidal diseases |
| Lauermann et al. | Retinal diseases | SD-OCTA | 30 | 56.00% | — | — | 38.30% | — | Lack of eye-tracking mode |
| Say et al. | Retinal diseases | SD-OCTA | 130 | 26.00% | — | 55.00% | — | — | Radiotherapy, visual acuity, sex |
| Chen et al. | Retinal diseases | SD-OCTA | 60 | 70.00% | — | — | 50.00% | — | NS |
| Present study | Glaucoma | SS-OCTA | 1363 | 17.31% | 21.35% | 4.11% | 1.61% | 0.37% | IQS, severity |
| Healthy | 3063 | 15.31% | 11.00% | 2.55% | 1.31% | 0.59% | IQS, female, AL |
NS, not studied; MS, multiple sclerosis.